Guardant Health
GH
#1010
Rank
NZ$42.05 B
Marketcap
NZ$313.38
Share price
-2.03%
Change (1 day)
212.27%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): NZ-$5.79

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is NZ-$5.92. In 2025 the company made an earnings per share (EPS) of NZ-$5.78 an increase over its 2024 EPS that were of NZ-$6.22.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.790.18%
2025NZ-$5.78-7.02%
2024NZ-$6.22-16.82%
2023NZ-$7.48-33.13%
2022NZ-$11.1860%
2021NZ-$6.9955.04%
2020NZ-$4.51207.14%
2019NZ-$1.47-19.81%
2018NZ-$1.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
NZ-$4.90-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
NZ-$4.33-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA